 Check-Cap Ltd. the Company or Check-Cap NASDAQ: CHEK, NASDAQ: CHEKZ, a clinical stage medical diagnostics company advancing the development of C-Scan, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into colorectal cancer, today announced financial results for the second quarter and six months ended June 30, 2020. 